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Currently 5.8 million Americans are living with Alzheimer’s disease (AD), which is a 
degenerative brain disease. It is currently the sixth leading cause of death in the United States 
(Alzheimer’s Association, 2019). AD also possess a financial burned on the United States, 
estimated to cost $290 billion in 2019. Sufferers of AD insidiously lose their memory, 
personality, and judgment abilities until there are no longer recognizable by their loved ones. 
Currently the best chance suffers of AD have is to catch the disease early on to slow its effects. 
This is due to the fact that treatment can only prevent and slow down the disease not improve on 
the condition of the patient. One way to effectively do this is determine the target population of 
individuals that are at risk of developing mild cognitive impairment (MCI). To do that the natural 
cognitive decline in a person must be separated from the unnatural cognitive decline due to MCI. 
To do this, a cross-sectional study design was employed comparing two groups of women, one 
of which was older and one was younger. During each test, their demographics were recorded 
and they completed four different cognitive tests. All the tests were validated to measure an 
individual’s cognition. The test that provided the results that were analyzed was the Repeatable 
Battery for the Assessment of Neuro-psychological Status (RBANS), and the Dual-Task test. 
Ten younger subjects (M = 60.7, SD = 5.2) and 29 older subjects (M = 21.0, SD = 0.6) were 
tested. After statistical analysis of the RBANS scores of each group it was determined that the 
older group tested significantly better than the younger group on all aspects of the test. This 
could have been for potential distractions in the younger group due to COVID complications or 
the higher education level of the older group compared to the younger group. It could also mean 
that cognition steadily increases until a tipping point that might be after the age of 70 years.  
 




Alzheimer’s disease (AD) is a degenerative brain disease, meaning it becomes worse 
with time. In 2019 5.8 million Americans are living with AD, and this number is expected to 
grow as the population of age 65 and older continues to increase. Between the years of 2000 and 
2017 there was a 145% increase in deaths caused by AD, making it now officially the sixth-
leading cause of death in the United States. On average a person with AD survives somewhere 
between 4 to 8 years after their diagnosis, but some can live as long as 20 years after a diagnosis. 
However, those 20 years the patient is living with this disease are extremely taxing on not only 
the patient but also the family (Alzheimer’s Association, 2019). These statistics show just how 
slow, insidious, uncertain, and difficult AD can be. Not only can AD lead to death but it is also 
the leading cause of disability and poor health, also known as morbidity. Most AD sufferers must 
deal with years of morbidity as the disease gets worse before they pass. AD is a costly disease, 
and not only is it costly for the United States economy it is also costly for individuals who are 
suffering. In 2019, it was estimated that AD would cost over $63 billion out of pocket for those 
suffering (Alzheimer’s Association, 2019). Even though Medicare and Medicaid can help, AD 
still possess a burden to the families of the affected. AD diminishes a patient’s quality of life as 
they slip so far away until they can no longer care for themselves. This also results in increase 
caregiver distress and accelerates nursing home placements (Cummings, 2005). 
AD is also difficult to diagnose early on. Physicians do not have a difficult time 
determining if a patent has dementia but they do often have a difficult time determining what the 
cause is. Although AD is the most common cause of dementia, there are many other causes of 
dementia in patients aside from AD. To make this more difficult there is no one test for dementia 
caused by AD (Alzheimer’s Association, 2019). Patients often have to undergo many tests and 
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steps in order to get a positive diagnosis for AD. This might entail considering medical and 
family history, having a family member provide experience with the patients changes in 
cognitive skills and behavior, cognition tests, physical and neurological exams, blood tests, and 
brain imaging (Alzheimer’s Association, 2019). Often this testing does not even start until the 
dementia is noticeable in a patient. By this point cognitive skills have changed or deteriorated so 
much that the patient will be noticeably different. Since treatment for AD cannot improve the 
state of the patient, only slowing the progression of the disease, it would be much more 
beneficial if the disease was caught before these symptoms were noticeable.  
Not only is AD difficult to diagnose it is also difficult to treat. Currently there are no 
treatments in the form of medications that can stop or slow the damage done to neurons by the 
disease, which in turn cause the symptoms seen in AD patients. The medications that are 
available can temporarily improve the symptoms but are not a long-term solution as they are 
limited in duration. Developing pharmacologic treatment for AD is also difficult to do for many 
reasons. This is due to the difficulty in recruiting patients with AD to participate in studies, lack 
of knowledge of the molecular changes AD causes, and the time it takes to determine if a 
treatment is effective or not. Moreover, it is widely believed that the most effective treatment of 
the disease is done early on in the disease process, meaning it must be identified in a patient 
early on (Alzheimer’s Association, 2019). Which as previously stated is difficult to do.  
 Even if there is a treatment developed that is effective in treating the disease one of the 
most crucial aspects in managing the disease is detecting it early on. This is still difficult to do. 
Currently the best chance there is at detecting the disease early on is through cognition testing. 
There have been many ways of testing cognition developed and currently developing, with most 
being reliable measures of an individual’s cognition levels. For the examiner to determine if the 
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person being tested is at risk for developing the disease, or even a mild cognitive impairment, 
many of these tests require the individual to be tested multiple times over a long period of time. 
The more recent scores are then compared to the later ones and if a significant decrease in the 
cognition levels is detected the individual is labeled as at risk for developing a mild cognitive 
impairment. However, if there is naturally a decrease in cognition over time would this attempt 
at diagnosis be done in vain? Therefore, it is important for the natural decrease in cognition over 
time to be determined so that the outliers can be separated from those that have a completely 
normal decrease in cognition as they age.  
Literature Review 
        There is no current cure for Alzheimer’s, though it looks hopeful that there are ways to 
delay its onset by a significant amount. In fact, many studies have focused on this hope. For 
example, one research group has found that delaying the disease progression is quite feasible 
even though prevention of the disease is not. They found that the most promising method for 
treatment to be controlling vascular risks. These vascular risks include hypertension, physical 
exercise, and even mental exercise (Larson, 2010). The first step in delaying the onset of this 
disease is being able to detect it early in patients. To do this risk factors should be identified, 
measured, and tracked over time. Then it could be possible to alter the negative trajectory of the 
disease or even catch it before it is even a disease. One group has successfully executed this 
measurement with the Cardiovascular Risk Factors, Aging, and Incidence of Dementia Risk 
Score (CAIDE). The CAIDE is a tool that is used to predict late in life dementia risk, which is 
based on midlife vascular risk factors. It is used to identify individuals that are at risk for 
developing either AD or a mild cognitive impairment (MCI) (Sindi et. al., 2015). CAIDE was 
also used in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and 
Running Head: COGNITION OVER TIME 
 
8 
Disability (FINGER). The FINGER study used CAIDE to determine the at-risk participants 
invited into the study. Then the lifestyles of the participants were modified to determine the 
effect of lifestyle intervention on preventing cognitive impairments among individuals at risk for 
development of AD. The results from FINGER trial found that lifestyle modification effectively 
delayed the onset of MCI; it showed a 25% increase in the cognition of the at-risk individuals 
who participated over the 2-year period (Ngandu et. al., 2015). There have been many tests 
created in the hopes of detecting older individuals with cognitive declines that qualify for a MCI 
or AD. Many of these tests were promising. However, currently there is no validated test that can 
determine preclinical changes in cognition over time. There are tests, such as those used in this 
study, that have shown promise in measuring cognition. With all of this in mind, the purpose of 
this study was to first measure the cognition in women of two age groups and compare the 
results. This is done in the hopes that the normal decline in women over time can be determined 
so that those with an unusual decline in cognition can be identified as early as possible. Because 
if those women can be identified they can use methods, such as lifestyle modification used in the 
FINGER study, to hopefully delay the onset of MCI or AD. 
 One test that has been popular in the testing of MCI was developed by a research team in 
Montreal. The Montreal Cognitive Assessment (MoCA) was developed so that physicians had a 
quick, easy, and cheap way to test their patients for MCI. The test was developed to cover eight 
cognitive domains and was tested on 94 patients that met the criteria for an MCI as well as 90 
individuals that did not. They found the test to be a successful screening tool to detect MCI in 
individuals. The study suggests MoCA to be highly sensitive and specific in detecting. MoCA 
detected 90% of the patients with MCI while a popular different test only had an 18% success 
rate (Nasreddine et. al., 2005). Though this test seems to be the perfect solution for testing for 
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Alzheimer’s it has not been without its issues. Davis and his team set out to determine the 
diagnostic accuracy of the MoCA test for various different thresholds of dementia. They found 
that the test produced a high proportion of false positives, which can be misleading to 
individuals. They found that up to 40% of people who did not have dementia tested as a false 
positive when taking the MoCA test (Davis et. al., 2015).   
 A more resent way researchers have tried detecting cognitive impairments is through the 
Visual Paired Comparison (VPC) task. This test uses a web camera and eye tracker software to 
detect MCI in subjects. The software can estimate cognition levels by using a web-cam to 
measure the time spent looking at novel versus previously seen images. First to determine if the 
software worked in tracking eye movement, Bott et al. 2017 tested the software on 54 deemed 
cognitively normal older adults, each being tested three times using the VPC test. Using Pearson 
correlations, the researchers found the software was successful in tracking eye movements on 
decisional tasks. They also found the software to have high accuracy while still being low cost 
(Bott et. al, 2017). A team of researchers here at the University of Arkansas had an idea that this 
software could be used to detect early signs of MCI so they decided to test this theory. Gray and 
colleagues (2019) tested 51 individuals using MoCA and the VPC assessment. They used a web 
camera to track the eye movements of the participants. This was done to measure the time spent 
locating a novel image in comparison to a preciously viewed image. They found the software to 
be a viable way to screen for cognitive impairments. It correctly identified 90% of adults as 
either cognitively impaired or cognitively intact. Specifically, 95% of those with cognitive 
impairments were correctly identified as having a cognitive impairment through the test. They 
found it to be a good alternative to in-person assessments done in the physician’s office as well 
as an easily assessable test. (Gray et. al., 2019) 
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 A test for MCI is not required to be completed sitting down, a research team in 
Edinburgh found a way to detect MCI using physical tasks. Previous studies have shown that 
MCI’s can impair the dual task abilities, which involves walking while doing a secondary task, 
of patients. One of these studies was conducted by Montero-Odasso et. al. (2009) and his team 
with BioMed Central. Eleven elderly participants with MCI were tested in two sessions using six 
gait parameters. They were tested for a single task walk and a dual task walk, the dual task 
consisted of having the participants count backwards from 100 until the end of the walk, which 
was 600 cm in length. The team found that under the dual task condition the participant’s gait 
speed decreased significantly. This meant that they walked significantly slower during the dual 
task compared to the walk without the dual task. This suggested firstly, a cognitive connection to 
gait performance and secondly, an impairment of dual task abilities with MCI (Montero-Odasso 
et. al., 2009). With this information, Dr. Foley and her team decided to create a dual task test that 
could detect AD. They tested this assessment on 50 people with AD, 50 heathy controls, and 49 
people with MCI. They found that the group with AD performed significantly worse on the dual 
task assessment than the group with MCI. Interestingly they also found that the group with MCI 
performed relatively similar at the dual task assessment to the healthy group. Of the three groups 
the AD group scored lowest on digit recall, tracking, dual task performance, and overall. The 
digit recall required the participants to cross out boxes arranged in a path around a sheet of paper. 
For the tracking task the participants followed a moving square using a light sensitive pen on a 
computer screen.  They also found that typical ageing had no impairment on the performance of 
subjects (Foley et. at., 2011).  
 Someone that has a MCI has a cognition level that is below the average level of 
cognition. However, many studies have suggested that the average cognition level of an older 
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age group is expected to be lower than that of the younger age group. This is due to the natural 
decrease in cognition over time. These declines typically do not arise until the age of 65 and up 
(Cornelis et. al., 2019). So, it would be unwise to compare the cognition level of someone 65 and 
over to the overall average cognition level in individuals significantly younger. To better find 
those that are below the typical level of cognition that are at risk for MCI the natural decline in 
cognition needs to be determined.  
Freeman et. al. (2009) considered the physiology behind the natural decline in cognition. 
They found this age-related decline to be associated with many different factors. Those factors 
included changes in the glucose utilization of the brain, neurotransmitter levels, the expression of 
proteins in the body, and trophic factors. The neurotransmitters they were interested in 
specifically were dopamine, norepinephrine, 5-HT, GABA, and acetylcholine. The trophic 
factors they were looking at were brain-derived neurotropic factors, nerve growth factors, and 
insulin-like growth factors. The proteins they were interested in calcium regulatory proteins, 
synaptophysin, excitatory and inhibitory neurotransmitter receptors. They found that both 
glucose utilization and ATP generation decreased in the hippocampus of rats with aging. The 
changes in these levels leads to a decrease in neural processing with aging. They however were 
not able to distinguish whether these changes in the body due to age were the cause or the effect 
of the natural decline in cognition. Though they could identify what exactly the natural decline in 
cognition is, and they found it to be alterations due to age in dendritic and synaptic morphology 
in the neurons. (Freeman et. al., 2009). They found all of this through studying the changes in the 
hippocampal proteome, which is the entire set of proteins, in aging mice. Specific changes they 
found in the mice include a decrease in phosphatidylethanolamine binding proteins in the 
hippocampus, as well as increased heat shock proteins in the hippocampus in both humans and 
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mice with age. So, it must be kept in mind that the physiological changes in the human brain 
could be different than found in this study. However, this study was still a good start for the 
physiological background to the natural decline in cognition over time.   
In 2009, a conceptual model of cognitive aging was proposed called the Scaffolding 
Theory of Aging and Cognition (STAC). This theory used neuroimaging of the structural and 
functional aspects of the brain to explain the neurophysiological factors that are typically 
associated with aging. This model was a cross-sectional study that compared groups of younger 
and older adults and incorporated principles that would play across the lifespan. They found that 
healthy older adults were subject to varying degrees of neural degradation. The model states that 
aging causes two changes in the brain, that being neural challenges and functional deterioration. 
The neural challenges are structural changes in the brain that come with age. That includes things 
like shrinkage, changes in white matter, dopamine depletion, and more.  The functional 
deterioration represents things such as decreased specificity of ventral-visual and motor areas, 
increased default activity, and decreased recruitment of medial temporal lobe regions. The 
combination of neural challenges and functional deterioration combined then have a direct effect 
on the level of cognitive function in an individual as they age (Reuter-Lorenz et. al., 2014).  
Now that the natural decline in cognition has been discovered it still begs the question of 
when exactly does cognition begin to decline in an individual. This information is important so 
that relevant interventions can implement at the earliest possible time. The earlier a decrease in 
cognition is found the earlier treatment can be implemented. The earlier treatment is 
implemented the more effective it can be. Salthouse (2009) has tried to answer this question 
when he tested 2,350 participants between the ages of 18 and 60. The participants completed a 
battery which consisted of 12 different cognitive tests two different times. It tested aspects of 
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cognition like memory, reasoning, spatial visualization, speed, matrix reasoning, form boards, 
and pattern comparison. His data suggested that the age-related decline in cognition starts 
relatively early in adulthood when they are in their 20s or 30s. However, he could not detect the 
exact time in which it began. He also surprisingly found that not all cognitive functioning aspects 
exhibit a decline due to age. It turned out that performance on vocabulary tests or general 
information increased until at least the age of 60 unlike other aspects of cognition (Salthouse, 
2009).  
One way to study the natural decrease in cognition over time is to test the cognition levels 
of individuals’ multiple times throughout their life time. This type of study is difficult to conduct 
though yields more accurate results than testing different individuals of different ages and 
comparing their cognition levels to each other. Schönknecht et. al. (2005) tried this method. They 
studied upwards of 500 people over the course of four years. At the start of the study 13.4% of 
the subjects tested for an age associated cognitive decline. At the end of the four years that 
number increased to 23.6%. Those who showed signs for an age-related cognitive decline had 
reduced performance on all the cognitive aspects tested on their last trial compared to their first. 
Interestingly, a significant decline in performance was in the verbal memory portion of the test. 
They also found that this decrease in cognition was not a predictive of future cognitive 
impairments showing that it was natural and in no way abnormal (Schönknecht et. al., 2005). 
This leaves the question of when does this decrease become abnormal and is there a threshold 
when the decline becomes an indicator for MCI or even AD? 
One question that these tests have overlooked is what causes this natural decline in 
cognition? One research team at the University of Virginia have tried to answer this question 
through neuroanatomical substrates in the brain. Neuroanatomical can be defined as the neural 
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tissue of the nervous system. In basic terms, they believe that age related changes in the brain 
structure cause the cognitive changes associated with the natural decline in cognition. They 
reviewed various literature and studies done on the relationship between the neuroanatomical 
substrates and age related cognitive decline. After reviewing they found that this relationship was 
weak in current research (Salthouse, 2011). 
Even though the decline in cognition due to age is natural not everyone experiences it and 
some have even looked into how it can be prevented. Orbi, Khrimian, Karsenty, and Oury found 
that a bone derived hormone called osteocalcin can be important in preventing this decline. 
Though osteocalcin is typically associated with the skeletal regulation of energy it also has an 
important role in regulating other physiological functions and developmental aspects. 
Specifically, it helps regulate the development and function of the brain. The researchers studied 
these levels of osteocalcin as well in comparison to the cognitive levels of mice. They found that 
increased levels of osteocalcin lead to a decrease in the decline in cognition over time. This lead 
them to believe that it was a hormone that could prevent the decline in cognition due to age (Obri 
et. al., 2018). Just as stated with a previous study since mice were used there is a chance that the 
physiology could be different in humans.  
When thinking of the variables that can affect cognition and in return effect the study of 
cognition one of the greatest factors that can affect it is sex. Its widely known that there are 
differences in cognition between sexes. It has been found that males tend to perform better than 
females in motor cognitive tasks as well as spatial cognitive tasks. On the other hand, women 
perform better on emotional identification as well as nonverbal reasoning (Satterthwaite et. al., 
2014). Keeping this in mind it makes sense to question whether gender also effects how 
cognition declines over time. Gur and Gur conducted a study comparing differences many 
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differences between the genders when going through the process of aging. One of these 
differences was in cognition. They used magnetic resonance imaging (MRI) during 
neuroimaging studies to compare the effects of aging on men and women in the areas of 
cognition and emotion. One thing they found was that the progressive decrease in brain volume 
due to aging affects the frontotemporal brain regions, which are associated with memory, 
attention, and inhibition, in men more than it does in women. They also found that age-related 
decline in cognition begins earlier in men than it does in women, by around 10 years(Gur et. al., 
2002). 
Methods 
         Two groups of women were recruited to participate in this study. The first group 
recruited were women between the ages of 18 and 40, and the second group recruited were 
women over the age of 40. The participants were asked to complete a questionnaire assessing 
both their mental and physical well-being to further identify any outside factors that could 
influence the tests. The first part of the questionnaire was an informed consent agreement that 
they were asked to fill out. The questionnaire as well as the informed consent was completed 
before each participant’s study. For demographics the age, weight, height, sex, and body 
composition of the participants were recorded. To test the body composition of the participants a 
DXA scan was completed at the end of the sessions. 
         Each session was completed in the Health, Physical Education, and Recreation building 
with a researcher. Because some of the participants could have had a potential cognitive 
impairment it was important that the researchers knew whether they had the capacity to consent 
to the test. That is why at the beginning of the session they were evaluated using the Montreal 
Cognitive Assessment. Which is a 10-minute assessment testing short term memory recall, 
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visuospatial abilities, executive functions, phonemic fluency, attention, concentration, working 
memory, and language. MoCA has been found successful in deciphering those that have a true 
developing MCI against those that simply have a natural cognitive decline due to age 
(Nasreddine, et at., 2005). If the participant had failed the MoCA assessment they would have 
required a guardian to sign their consent agreement.   
         Over the course of their session the participants took two stationary cognition tests, a 
demographic data analysis, and a mobile cognition test. The first stationary cognition test was the 
Visual Paired Comparison Test. This test uses the web camera in a laptop as a tool to measure an 
individual’s cognition. VPC focuses on the recognition memory of the participant and measures 
it by comparing the time the participant views a new picture to the time they spend on a previous 
picture. Before the test was conducted the participants are familiarized with a group of pictures, 
these are the previous pictures. After they are familiar with those pictures they were asked to 
focus their sight on the new picture when compared to the previous pictures. The software used 
by VPC tracks the participants eye movements while they are looking at the pictures on the 
screen, and can determine which image they are looking at and how long it took them to focus on 
the new image. The participants that take a longer time to focus on the new image have lower 
cognition and can be at risk for MCI or AD (Bott et al., 2017). 
         The next stationary test the participants completed was the Repeatable Battery for the 
Assessment of Neuro-psychological Status (RBANS). This test was created specifically with the 
purpose of identifying dementia in older individuals, as well as characterizing it. It tests many 
different aspects of the participant’s cognition. RBANS was validated to detect dementia and 
identify distinct profiles of impairment that distinguished the patients with dementia from 
individuals that did not have dementia (Randolph, et al. 1998). The test specifically focuses on 
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five different aspects of cognition: immediate memory, visuospatial/constructional, language, 
attention, and delayed memory. To test these aspects of cognition there are ten different trials 
during the test, with two different trials for each aspect of cognition. The immediate memory 
portion includes a list learning test and a story memory test. The visuospatial/constructional 
portion includes a figure copy and a line orientation test. The language portion includes a picture 
naming activity and a test of semantic fluency. The attention portion includes a test of digit span 
and a test including coding. Finally, the delayed memory portion calls back to the list and story 
told at the beginning of the test.  
         As previously stated for every session a mobile cognitive test was conducted in between 
the second and third stationary cognitive tests. During this time hand grip strength was also 
recorded using a Takei Handgrip Dynamometer. The grip strength of each hand was taken three 
times on each hand, alternating between hands after each time to decrease fatigue. The mobile 
test done in this study was a dual-task assessment. Several studies have found that some of the 
early symptoms of memory impairment has been linked with dual-tasking ability (Foley, et al., 
2011). During this test, the participants completed four 20 meter walks, each of which being 
different. The sensors were set up to be at the 5 meter and the 10-meter mark of the walk in order 
to measure the time the participants took to walk from the 5 meter mark to the 10 meter mark.  In 
a test of 50 people with AD, 49 people with a MCI, and 50 people without cognitive impairments 
the dual task test was proved to be valid and reliable in testing for AD. However, in this test it 
was not proven to be valid or reliable in testing for MCI amongst healthy individuals (Foley et. 
al., 2011). Montero-Odasso found the dual-task test to be a reliable study in determining older 
individuals with MCI. They found the variability in the time taken during the dual task 
assessment in comparison to the control test were increased in older people with MCI (Montero-
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Odasso et. al., 2009). The first two walks were done at a typical walking pace. The second of 
which was done with an additional math task, which composed of counting backwards from a 
randomly generated number by threes. The second two tasks were conducted the same way but at 
a faster walking pace. 
For statistical analysis, the differences in the cognitive assessments were assessed. The 
results of the two age groups were compared against each other during the analyses.  
Results 
Table 1. Demographics of study sample. Includes Gender, Mean age, Highest level of education, 
and room study was completed in.  
 Older Younger 
Variable n=29 n=10 
Gender 
            Female 
Age (Mean) 
Schooling 
            Bachelor’s Degree (including      
c          currently working towards one) 
            Past Bachelor’s Degree 
Room Assignment 
           Pre COVID Room 




















A total of 39 participants completed the study. Of which 29 were older participants 
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between the ages of 50 and 69 (M = 60.7, SD = 5.2). The remaining 10 participants were younger 
between the ages of 20 and 21 (M = 21.0, SD = 0.6).  All participants completed the full study 
completing a MOCA test, a RBANS test, a VPC test, a Dual task test, a hand grip test, 
demographics, and a DXA scan. The study began just months before the COVID pandemic 
started, which effected how the study was conducted specifically in the room it was taken in. 
After the quarantine ended and testing resumed the original room that was designated for this 
study was deemed too small for two individuals to occupy at the same time. Because the study 
required that the participant and the researcher to occupy the same room at the same time, the 
test had to be moved into a larger room. The room that the study was then moved to happened to 
also act as a breakroom for some professors and graduate students in the laboratory. Because of 
this there would sometimes be interruptions during a participant’s test, most likely disrupting 
their concentration and potentially effecting their results. All the younger subjects and half of the 
older subjects were tested after the pandemic began and subsequently were tested in this 
breakroom. The remaining older participants were tested before the pandemic began in the 
smaller room which posed no interruptions during testing.  
The average weight of the older participants was 72.03 kg. The average weight of the 
younger participants was 65.41 kg. The average height for the older participants was 163.37 cm. 
The average height for the younger participants was 165.75 cm. The RBANS test was divided 
into five different sections testing five different aspects of cognition. The test provided a score 
for four of the five sections as well as a total score. Those sections were memory, 
visuospatial/constructional, attention, and delayed memory. The scores were reported in the form 
of percentiles. With the percentiles, a score of 60 for example means the individual performed 
better than 60 percent of the population. The scores for the younger group and the older group 
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were separately analyzed. For each section where a percentile was provided the mean and 
standard deviation for each group was calculated. Table 2 lists all the means and standard 
deviations from the RBANS test.  
Table 2. Means and Standard Deviations of RBANS Scores for both groups. Scores are listed as 
percentiles and separated by section. In addition to Significance or P value found by comparing 
the percentiles of both subject groups. 
Item        Younger      Older  Significance 
 M          SD              M SD P Value 
RBANS Score:      
Memory percentile                    
Visuospatial/constructional percentile               
Attention percentile                 
Delayed memory percentile             
Total percentile                     
28.40                  
44.70        
47.10              
44.51           
35.70           
24.45             
25.15             
27.04         
20.31           
21.93            
65.97           
70.14           
68.69                
65.62           












 The mean percentiles from each group were then compared to each other. This was done 
to find if there was a statistically significant difference between the two values. This was done 
for each section of the RBANS test as well as the total. These results are listed in Table 2. It was 
found that there was a statistically significant difference between the scores of the two groups for 
every section and the total score. The older women scored 43% higher on the Memory section, 
63% higher on the Visuospatial/Constructional section, 68% higher on the attention section, 67% 
higher on the delayed memory section, and 48% higher total compared to the younger women. A 
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difference is found to be statistically significant if its p value is found to be less than 0.05 and all 
the differences tested provided a p value lower than that of 0.05.  
 The younger group of participants mean score was in a lower percentile than the older 
group of participants for every section of the RBANS test as well as in the total score. In three of 
the four aspects of cognition that were tested the older groups minimum and maximum score 
were both higher than the minimum and maximum scores of the younger group respectively. The 
only section that the older group did not out score the younger group in the minimum and 
maximum scores was the Visuospatial/ Constructional section. The only reason for this was that 
the older groups minimum score was the same as the minimum score for the younger group. 
However, for this section their maximum score was still higher for the older group than the 
younger groups.  
Discussion 
There was an obvious difference in cognition found between the groups. While a 
significant decrease in cognition was not found between the two groups of subjects a significant 
increase in cognition was found. None of the confounding variables tested for were found to 
have any significant effects on the results. Those confounding variables tested for included body 
mass, height, and hand grip strength. These results give room to the idea that instead of steadily 
decreasing overtime, cognition levels may instead steadily increase. That is until at least the age 
of 70. When considering what was found in this study all that is known at this point is that 
cognition increases until at least the age of 70.  If cognition does decline, when considering the 
results from this study, it would have to happen past the age of 70. This would be because no 
participants over the age of seventy were tested during this study. However, there is some room 
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for bias in the test. It is impossible to run a test without some potential for bias. The fact that half 
of the older individuals were tested in a room without the same distractions that the other 
participants had to face could have potentially skewed results. It has been found that auditory 
distractions during memory tasks can minimize a participant’s control over their own memory 
processes. Auditory distractions have also reduced a participant’s confidence in their responses 
during cognitive tests. Which in turn increases their chances of withholding responses in free-
report recognition (Beaman et. al., 2014). The distractions that happened in the room used after 
the COVID pandemic began were not only auditory distractions but visual ones as well. This 
very well could be a potential explanation for the significant increase in scores amongst the older 
participants.  
Another potential biased in the test related to the education levels of the participants. 
Since the recruitment process for participants happened mainly on or around the campus of the 
University of Arkansas most subjects were in some way related to the University. For the 
younger participants, this meant undergraduate students completing their bachelor’s degree. 
However, for the older participants this meant University professors who had already completed 
their doctoral degrees. In fact, 9 out of the 29 older participants tested had completed some 
education that was higher than a Bachelor’s degree. The fact that most of the older participants 
had approximately more than 8 and a half years of higher level education more than the younger 
students could be another explanation for the significant difference in cognitive levels between 
the groups. In one study, it was found that elderly participants who completed primary school 
scored 18.2% higher than individuals who did not complete primary school on cognitive tests 
(Huang et. al., 2013). If the presence or absence of primary school has that large of an impact on 
cognitive levels later in life the presence or absence of higher education could also have some 
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impact on cognition levels. However, a different study that used the MoCA test used in this study 
tested individuals with three different education levels; less than primary, primary, and more 
than primary. They found no differences in the total scores or most of the sub scores. The only 
difference they found between the groups was in the language sub score (Yancar Demir et. al., 
2015).  
There are limited studies focused on the gradual increase in cognition overtime, but there 
have been some that have found evidence for it. Most of these studies start out with similar goals 
to this one in proving the natural decrease in cognition over time. One potential explanation for 
the increase in cognition levels over time is that the stability of cognition increases with age. 
This was found in a study that focused on the stability of cognition and personality with age. 
They also found that the increase in stability of cognition with age is mainly mediated by genetic 
factors (Briley et. al., 2015). Reuter-Lorenz revisited the Scaffolding Theory of Aging and 
Cognition (STAC) found that aging was associated with reduction in things like white matter 
integrity, cortical thickness, functional engagement in the posterior brain regions, and 
dopaminergic activity. However, they also found that there are increases in the engagement of 
the frontal area of the brain that can be correlated with increased behavioral performance with 
age (Reuter-Lorenz et. al., 2014). 
Conclusion 
 The purpose of this study was to compare the cognition levels between two different 
groups of women varying in age. It was originally conducted to determine the natural decrease in 
cognition over time. However, the results of this study suggest that prior to former ideas that 
cognition levels increase with age. That is until at least the age of 70. The group of older 
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participants scored significantly higher than the group of younger participants on the RBANS 
test conducted. The older groups mean score and range was higher than the younger groups 
scores in every section of the test as well as in the total score. There were some potential bias in 
the results. Due to the COVID pandemic all the younger participants had to be tested in a larger 
room with more distractions than most of the older participants. These distractions could account 
for the lower scores in the younger group. Most of the older group had higher levels of education 
than the younger group. That of which could have accounted for the difference in scores. Or 
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